March 29, 2026. 13 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
Dan Patrick adds data centers, prediction markets and THC to Senate priorities
Summary Texas Senator Dan Patrick’s legislative priorities for 2027 include studying THC regulation alongside data centers and prediction markets, representing potential policy developments affecting cannabis oversight.
Read more →Schaumburg family still advocating improvement of state and federal medical marijuana laws
This article documents a family’s advocacy efforts regarding medical marijuana policy improvements at state and federal levels, potentially offering clinicians insight into patient perspectives on regulatory gaps.
Read more →Scientists say the evidence is clear: E-cigarettes beat patches and gum in helping smokers quit
Summary This article reports findings from a large review examining mental health effects associated with high-potency cannabis products, relevant to clinicians assessing patient risks.
Read more →As restrictions on cannabis relax, scientists are investigating long-held beliefs about … – Facebook
Article Summary Scientists are investigating long-held cannabis beliefs as restrictions ease, potentially contributing to evidence-based clinical understanding of the plant’s therapeutic profile.
Read more →Experts On Aging Reveal The 5 Major Habits That Will Improve Your Longevity
This article discusses longevity habits from aging research experts, which may interest clinicians seeking to understand broader health factors affecting patient outcomes and lifestyle counseling.
Read more →Rome Woman Arrested After Traffic Stop Turns up Numerous Types of Drugs
A Rome woman was arrested on drug charges following a traffic stop, potentially relevant to clinicians tracking cannabis prevalence in polydrug use cases.
Read more →Pregnant U.S. Visitor Admits to Cannabis Possession at Antigua Airport
A U.S. woman pleaded guilty to cannabis possession at an Antigua airport while pregnant, illustrating legal consequences of international cannabis transport and potential clinical considerations for pregnancy-related cases.
Read more →In support of cannabis dispensary prohibition | Garrett Opinion | wvnews.com
This opinion piece discusses arguments for cannabis dispensary prohibition, referencing federal illegality and drug-related concerns in Maryland—potentially relevant to clinicians tracking policy advocacy and regulatory perspectives.
Read more →Assessing Tenet Healthcare (THC) Valuation After A Recent Share Price Pullback
This article analyzes Tenet Healthcare’s stock valuation following recent price declines; it may interest cannabis clinicians tracking healthcare sector trends relevant to medical cannabis program development.
Read more →Chair Powell Says There Is ‘no Risk-free Path’ Ahead For The Federal Reserve [1bf9b0] – Fathom
This article appears to be misclassified; it discusses Federal Reserve monetary policy rather than cannabis. It contains no relevant clinical content for cannabis practitioners.
Read more →Accused shoplifter’s getaway car got away without her: Orange Police Blotter
Article Summary A police blotter item documenting evidence collection during an arrest, including a marijuana cigarette seized alongside other contraband during a traffic stop.
Read more →Article Summary This article appears to be a Christian Broadcasting Network piece on recreational marijuana, potentially offering a religious or faith-based perspective on cannabis policy or use that may interest clinicians studying patient beliefs and values.
Read more →In a major crackdown, Pune Customs seized 76.58 kg of hydroponic marijuana worth ₹26.8 …
Pune Customs seized 76.58 kg of hydroponic marijuana, demonstrating evolving cultivation methods that may interest clinicians monitoring cannabis supply chain changes and product potency trends.
Read more →Digest-Level Clinical Commentary
These digest items reveal a fragmented landscape where cannabis policy is advancing at the legislative and political level, yet the evidence base for clinical practice remains constrained by federal restrictions that limit rigorous research and clinical standardization. The few items touching on science underscore what we face as practitioners: reliance on small-scale studies and anecdotal data while high-potency products proliferate in the market, creating a disconnect between what patients can access and what we can confidently prescribe based on robust clinical evidence. For cannabis medicine to mature as a legitimate specialty, we need independent, large-scale clinical trials alongside sensible federal rescheduling, not just political momentum and market expansion.
These items reflect several concurrent developments in cannabis policy and research: regulatory changes are accelerating at state and federal levels while scientific evaluation of cannabis health effects remains incomplete, creating gaps between policy momentum and evidence-based understanding. Clinical attention is shifting toward understanding both potential therapeutic applications and documented risks, particularly regarding mental health impacts in high-potency products and use during pregnancy. Enforcement disparities persist alongside evolving legal frameworks, suggesting that policy standardization at federal and state levels has not yet resolved practical inconsistencies in how cannabis-related offenses are prosecuted and adjudicated.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it: